J&J Clinical Trials
Login
Back to search

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
Clinicaltrials.gov:
EU CTIS:
#2025-521976-80-00
Other:
#79635322MMY2001
Other:
#2025
Interested in this trial?
Subscribe or share this trial
Trial overviewLocationsEligibility
Countries:
  • China,
  • Israel,
  • Italy,
  • Japan,
  • Poland,
  • South Korea,
  • Turkey (Türkiye),
  • United States
Loading...
Enrolling
Roma, Italy, 00161
Enrolling
Bergamo, Italy, 24127
Enrolling
Ankara, Turkey (Türkiye), 06590
Enrolling
Seoul, South Korea, 05505
Enrolling
Cuneo, Italy, 12100
Enrolling
Florence, Italy, 50134
Enrolling
Palermo, Italy, 90127
Enrolling
Chaoyang District, China, 100020
Enrolling
O'Fallon, Illinois, United States, 62269
Enrolling
Verona, Italy, 37134
Enrolling
Jeollanam-do, South Korea, 58128
Enrolling
Afula, Israel, 1834111
Enrolling
Jerusalem, Israel, 9112000
Enrolling
Hadera, Israel, 3820302
Enrolling
Pavia, Italy, 27100
Enrolling
Istanbul, Turkey (Türkiye), 34381
Enrolling
Ankara, Turkey (Türkiye), 06680
Enrolling
Istanbul, Turkey (Türkiye), 34214
Enrolling
Antalya, Turkey (Türkiye), 07025
Enrolling
Waukee, Iowa, United States, 50263
Enrolling
Okayama, Japan, 701-1192
Enrolling
Gunma, Japan, 377-0280
Enrolling
Atlanta, Georgia, United States, 30342
Enrolling
Eugene, Oregon, United States, 97401
Enrolling
Beijing, China, 100006
Enrolling
Bologna, Italy, 40138
Enrolling
Pescara, Italy, 65124
Enrolling
Petah Tikva, Israel, 4941492
Enrolling
Aurora, Colorado, United States, 80012
Enrolling
Sakarya, Turkey (Türkiye), 54050
Enrolling
Krakow, Poland, 30 688
Enrolling
Ashdod, Israel, 7747629
Enrolling
Seoul, South Korea, 06351
Enrolling
Seoul, South Korea, 03080
Enrolling
Seoul, South Korea, 03722
Enrolling
Shanghai, China, 200434
Enrolling
Guangzhou, China, 510700
Enrolling
Kielce, Poland, 25 734
Enrolling
Brzozów, Poland, 36 200
Enrolling
Tel Aviv, Israel, 6423906
Enrolling
Nashville, Tennessee, United States, 37203
Enrolling
Seoul, South Korea, 06591
Enrolling
Lublin, Poland, 20 081
Enrolling
Wroclaw, Poland, 50 367
Enrolling
Poznan, Poland, 60-569
Enrolling
Fairfax, Virginia, United States, 22031
Enrolling
Norfolk, Virginia, United States, 23502
Enrolling
Torun, Poland, 87 100
Enrolling
Lodz, Poland, 93 513
Enrollment complete
Gilbert, Arizona, United States, 85234
Enrollment complete
Jacksonville, Florida, United States, 32256
Enrollment complete
Los Alamitos, California, United States, 90720
Enrollment complete
Duarte, California, United States, 91010
Enrollment complete
Irvine, California, United States, 92618
Enrollment complete
Cleveland, Ohio, United States, 44195
Enrollment complete
Denver, Colorado, United States, 80218
Enrollment complete
Atlanta, Georgia, United States, 30322
Enrollment complete
Charlotte, North Carolina, United States, 28204
Enrollment complete
Houston, Texas, United States, 77030
Enrollment complete
Boston, Massachusetts, United States, 02114
Enrollment complete
New York, New York, United States, 10065
Enrollment complete
Tacoma, Washington, United States, 98405
Enrollment complete
Birmingham, Alabama, United States, 35294
Enrollment complete
Houston, Texas, United States, 77030
Enrollment complete
New Brunswick, New Jersey, United States, 08901
Enrollment complete
Nashville, Tennessee, United States, 37203
Enrollment complete
Austin, Texas, United States, 78705
Enrollment complete
Tyler, Texas, United States, 75702
Enrollment complete
San Francisco, California, United States, 94143
Enrollment complete
Iowa City, Iowa, United States, 52242
Enrollment complete
Philadelphia, Pennsylvania, United States, 19104
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
Clinical trials information
About us
Key links
Get in touch
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials